title: Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.
abstract: Moraxella catarrhalis causes significant health problems, including 15-20% of otitis media cases in children and ~10% of respiratory infections in adults with chronic obstructive pulmonary disease. The lack of an efficacious vaccine, the rapid emergence of antibiotic resistance in clinical isolates, and high carriage rates reported in children are cause for concern. In addition, the effectiveness of conjugate vaccines at reducing the incidence of otitis media caused by Streptococcus pneumoniae and nontypeable Haemophilus influenzae suggest that M. catarrhalis infections may become even more prevalent. Hence, M. catarrhalis is an important and emerging cause of infectious disease for which the development of a vaccine is highly desirable. Studying the pathogenesis of M. catarrhalis and the testing of vaccine candidates have both been hindered by the lack of an animal model that mimics human colonization and infection. To address this, we intranasally infected chinchilla with M. catarrhalis to investigate colonization and examine the efficacy of a protein-based vaccine. The data reveal that infected chinchillas produce antibodies against antigens known to be major targets of the immune response in humans, thus establishing immune parallels between chinchillas and humans during M. catarrhalis infection. Our data also demonstrate that a mutant lacking expression of the adherence proteins MhaB1 and MhaB2 is impaired in its ability to colonize the chinchilla nasopharynx, and that immunization with a polypeptide shared by MhaB1 and MhaB2 elicits antibodies interfering with colonization. These findings underscore the importance of adherence proteins in colonization and emphasize the relevance of the chinchilla model to study M. catarrhalis-host interactions.
authors.affiliation: Department of Microbiology, University of Georgia, Athens, Georgia, United States of America.
authors.forename: Teresa L
authors.initials: TL
authors.lastname: Shaffer
authors.forename: Rachel
authors.initials: R
authors.lastname: Balder
authors.forename: Sean W
authors.initials: SW
authors.lastname: Buskirk
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Hogan
authors.forename: Eric R
authors.initials: ER
authors.lastname: Lafontaine
mesh_terms: D018829:Adhesins, Bacterial / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D001422:Bacterial Adhesion / Q000276:immunology; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D015153:Blotting, Western; D045744:Cell Line, Tumor; D002682:Chinchilla / Q000276:immunology* / Q000382:microbiology; D004195:Disease Models, Animal; D006193:Haemophilus influenzae / Q000276:immunology / Q000502:physiology; D006388:Hemagglutinins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D054884:Host-Pathogen Interactions / Q000276:immunology; D006801:Humans; D001936:Moraxella catarrhalis / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D045828:Moraxellaceae Infections / Q000276:immunology* / Q000382:microbiology; D009154:Mutation; D009305:Nasopharynx / Q000276:immunology / Q000382:microbiology; D010033:Otitis Media / Q000276:immunology / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000276:immunology / Q000502:physiology; D014611:Vaccination / Q000379:methods
chemical_list: D018829:Adhesins, Bacterial; D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D006388:Hemagglutinins